Anti-PKC epsilon (phospho S729) antibody
3
(1 Review)
|
(30 Publications)
Rabbit Polyclonal KPCE phospho S729 antibody. Suitable for WB and reacts with Human, Mouse samples. Cited in 30 publications. Immunogen corresponding to Synthetic Peptide within Human PRKCE pS729 aa 650 to C-terminus.
View Alternative Names
PKCE, PRKCE, Protein kinase C epsilon type, nPKC-epsilon
- WB
Unknown
Western blot - Anti-PKC epsilon (phospho S729) antibody (AB63387)
All lanes:
Western blot - Anti-PKC epsilon (phospho S729) antibody (ab63387) at 1/500 dilution
Lane 1:
HeLa cells treated with PMA (125ng/ml, 30mins) at 30 µg
Lane 2:
Jurkat cells treated eith PMA (125ng/ml, 30mins) at 30 µg
Lane 3:
NIH/3T3 cells treated with PMA (125ng/ml, 30mins) at 30 µg
Predicted band size: 84 kDa
Observed band size: 84 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PKC epsilon plays roles in regulating cell survival migration and apoptosis. It is involved in forming signalling complexes with proteins such as receptor for activated C kinase (RACK) and frequently associates with scaffolding proteins. PKC epsilon contributes to the modulation of cytoskeletal reorganization exocytosis and neurotransmitter release impacting cellular communication and function significantly.
Pathways
PKC epsilon is integrated into significant signalling cascades including the MAPK/ERK and PI3K/Akt pathways. These pathways influence cell proliferation differentiation and survival. PKC epsilon interacts with proteins like Raf-1 and Akt further modulating signals for cellular responses. Its activity and interactions within these pathways highlight its importance in maintaining cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
Theranostics 15:4247-4269 PubMed40225588
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 17:eadn8936 PubMed39078919
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 16: PubMed38339360
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 6: PubMed36625203
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 15:959224 PubMed36245919
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 10: PubMed35884957
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34884552
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34638477
2021
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:961 PubMed34385591
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecules and cells 44:569-579 PubMed34294609
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com